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Effect of hydroxychloroquine and characterization of
autophagy in a mouse model of endometriosis
A Ruiz1,7, S Rockfield1,7, N Taran1, E Haller2, RW Engelman3, I Flores4,5, P Panina-Bordignon6 and M Nanjundan*,1
In endometriosis, the increased survival potential of shed endometrial cells (which normally undergo anoikis) is suggested to
promote lesion development. One mechanism that may alter anoikis is autophagy. Using an autophagic flux inhibitor
hydroxychloroquine (HCQ), we identified that it reduces the in vitro survival capacity of human endometriotic and endometrial
T-HESC cells. We also identified that HCQ could decrease lesion numbers and disrupt lesion histopathology, as well as increase
the levels of peritoneal macrophages and the IP-10 (10 kDa interferon-γ-induced protein) chemokine in a mouse model of
endometriosis. We noted that RNA levels of a subset of autophagic markers were reduced in lesions relative to uterine horns from
endometriosis-induced (untreated) mice. In addition, the RNA levels of autophagic markers were decreased in uterine horns of
endometriosis-induced mice compared with those from controls. However, we noted that protein expression of LC3B (microtubule-
associated protein 1 light-chain 3β; an autophagic marker) was increased in uterine horns of endometriosis-induced mice
compared with uterine horns of controls. By immunohistochemical staining of a human endometriosis-focused tissue microarray,
we observed LC3B expression predominantly in epithelial relative to stromal cells in both eutopic and ectopic endometria. Via
transmission electron microscopy, cells from eutopic endometria of endometriosis-induced mice contained more lipid droplets
(rather than autophagosomes) compared with uterine horns from controls. Collectively, our findings indicate that the autophagic
pathway is dysregulated in both ectopic and eutopic endometrium in a murine model of endometriosis and that HCQ has potential
as a therapeutic agent for women afflicted with endometriosis.
Cell Death and Disease (2016) 7, e2059; doi:10.1038/cddis.2015.361; published online 14 January 2016
Endometriosis is a chronic, painful, and debilitating disease in
which endometrium-like glandular and stromal cells grow out-
side the uterine cavity.1,2 It is an inflammatory and estrogen-
dependent disease that affects 6–10% of women during their
reproductive years and up to 50% of women receiving fertility
treatments.3 Sampson’s hypothesis (the most accepted
theory) states that shed endometrial tissue during menses
reaches the peritoneal cavity by exiting the uterus through the
fallopian tubes by retrograde menstruation.4–6 These shed
endometrial cells survive, implant, and grow at ectopic
locations, developing into endometriotic lesions.5,7
Epithelial cells normally undergo anoikis, a mechanism of
programmed cell death, upon detachment from the extra-
cellular matrix.8 One mechanism that we propose could
potentially alter the anoikis response in endometrial cells is
autophagy. This cellular pathway needs to be carefully
regulated to maintain cellular homeostasis.9,10 Under condi-
tions of stress, changes in autophagic flux can lead to altered
cellular survival.9,10 Autophagy is a complex process that
begins with the formation of double-membrane vesicles,
termed autophagosomes, which engulf cytoplasmic compo-
nents. For a comprehensive review of the autophagic pathway,
refer to Feng et al.10 Briefly, autophagosomes fuse with
lysosomes to degrade and recycle their cargo comprised of
oxidized proteins, lipids, and damaged organelles. Presently,
there is limited evidence that autophagy contributes to the
development and progression of endometriosis. In a surgical
induction model of murine endometriosis, increased expres-
sion of ATG9A, an autophagic mediator that is involved in
vesicle formation,11 was detected in the eutopic endometria
from endometriosis-induced mice.12 In human endometrio-
mas (ovarian endometriosis), there was a reduction of LC3-II
(the conjugated form of LC3) protein compared with control
eutopic endometrial tissue.13 In contrast, an independent
study reported that the protein expression of LC3-II was
elevated, while p62 (which binds ubiquitinated cargo for
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degradation) was decreased in ovarian endometriomas com-
pared with eutopic endometria of disease-free participants.14
Herein, our main aim was to provide further evidence for a
role of autophagy in endometriosis development. Specifically,
we sought to determine the therapeutic effects of a lysosomo-
tropic agent and known autophagic flux inhibitor, hydroxy-
chloroquine (HCQ),15–17 on human endometriotic cells and in
an established mouse model of endometriosis. The results
presented herein are of high clinical translational value, as we
identify a potential new non-hormonal treatment for this still
incurable and common disease.
Results
HCQ alters human endometrial and endometriotic cell
survival as well as lesion number and histopathology in a
mouse model of endometriosis. To assess whether an
autophagic flux inhibitor could alter the survival capacity of
cells isolated from human endometriotic lesions, we treated
life-extended human endometriotic cells (cells were derived
from peritoneal (‘C’) and ovarian (‘D’) lesions obtained from
two independent patients and were thus tested separately)
with 25 μM HCQ. This dose was selected based on our
previous studies.18 As shown in Figures 1a and b, we
observed a marked reduction in cell survival of human
endometriotic cells from two different types of lesions
(Po0.0001) following 5 days of HCQ treatment. To validate
the activity of HCQ, we performed western blot analysis for
LC3B, which showed that LC3B-II increased with HCQ
treatment in these human endometriotic cells (Figure 1c). A
similar reduction in cell survival and increase in LC3B-II
protein was noted in the T-HESC human endometrial stromal
cells (derived from myoma, Supplementary Figure 1). To
confirm the effect of autophagy inhibition, we performed
siRNA knockdown for ATG5, beclin-1, ATG7, PIK3C3
(phosphatidylinositol 3-kinase, catalytic subunit type 3), and
LC3B in our human endometrial and endometriotic cells.
Although we failed to obtain suitable numbers of viable cells
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Figure 1 Continued.
Figure 1 HCQ reduces endometriotic cell survival as well as lesion number and histopathology in a mouse model of endometriosis. (a) Representative images of life-
extended endometriotic cells using human endometriotic cells derived from two different lesion types: ‘C’ and ‘D’ treated for 18 h with 25 μM HCQ. (b) Cell survival of life-extended
endometriotic cells treated with 25 μM HCQ for 5 days was assessed by CellTiter-glo and measuring luminescence. (c) Cell lysate from life-extended endometriotic cells treated
with 25 μM HCQ for 18 h were analyzed by western blotting using the indicated antibodies. Three independent experiments were performed. (d) Schematic representation of the
experimental design. Mice were intraperitoneally injected with β-estradiol at 6 weeks of age. After 1 week, these mice were killed and their uterine horns were removed, minced,
and injected into the peritoneal cavity of the same-age mice (recipients at 7 weeks of age). The same day of endometriosis induction, mice received an intraperitoneal injection of
HCQ or PBS. A second dose was administered 1 week later. Two weeks after induction, mice were killed and samples were collected. (e) The lesion numbers, area, and volume
per mouse are shown for HCQ- and PBS-treated endometriosis-induced mice. A subset of lesions (PBS- (n= 12) and HCQ- (n= 10) treated mice) was measured lengthwise and
widthwise to determine the area and volume. (f) Uterine horns and lesions from PBS- and HCQ-treated mice were subjected to H&E staining. Black arrowheads indicate glandular
compartments (top panels). Black arrows indicate epithelial cells (bottom panels). All images were captured at 10 × magnification
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upon transfection of human endometriotic cells for further
analysis, we successfully obtained 490% knockdown
efficiency of the above-described autophagic mediators in
T-HESC cells (Supplementary Figure 1d). Interestingly,
protein levels of p21 (a cyclin-dependent kinase inhibitor
involved in cell cycle arrest) markedly increased with siRNA
targeting ATG7 and to a lesser degree with LC3B and beclin-
1. Therefore, we selected these autophagic mediators to
investigate their effects on cell viability using the CellTiter-glo
assay in these cells. As shown in Supplementary Figure 1e,
the cell viability of T-HESC was particularly reduced with
ATG7 knockdown (and to a lesser degree with LC3B and only
slightly with beclin-1). These observations suggest that the
use of HCQ (or targeting specific autophagic mediators) may
be detrimental to both human endometrial and endometriotic
cell survival.
To determine whether treatment with HCQ alters the
formation of endometriotic lesions, we used an induced model
of murine endometriosis in which mice receive injections of
uterine horn fragments that develop into lesions within 2
weeks.19,20 We treated recipient (endometriosis-induced)
mice with 60mg/kg HCQ21 or phosphate-buffered saline
(PBS; Figure 1d). This treatment was repeated once every
7 days post-induction. Mice that were neither injected with
uterine horn fragments nor treated were used as controls
(Supplementary Figure 2a). All of the mice were killed at
the same time (14 days after endometriosis induction for both
the PBS and HCQ treatment groups). Ectopic lesions that
developed in the recipient mice (white arrow; Supplementary
Figure 2b) were counted, measured, and collected for RNA
and protein analysis, as well as for histological staining. No
lesions were observed in the control group (labeled as N;
Supplementary Figure 2b). The majority (87.5%) of
endometriosis-induced mice developed lesions. At the time
of collection, we noted that the endometriotic lesions varied in
size, color, and location across the treatment groups. As
shown in Figure 1e, there was a significant reduction in the
number of lesions that developed in mice treated with HCQ
compared with those treated with PBS (P= 0.0007; PBS-
treated mice, n= 24 (with a total of 46 lesions) and HCQ-
treated mice, n=25 (with a total of 18 lesions)). However,
there was no significant difference in lesion size or volume
between these two treatment groups (Figure 1e).
A randomly selected subset of the collected lesions and
uterine horns were processed for staining with hematoxylin
and eosin (H&E) (pathologically confirmed endometriotic
lesions from PBS- and HCQ-treatedmice, n=15 each; uterine
horns derived from PBS-treated mice, n=10; and uterine
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Figure 2 HCQ treatment increases the numbers of peritoneal macrophages and chemokine levels of IP-10. (a) Peritoneal fluid collected for control and recipient mice were
analyzed for 32 cytokines/chemokines. The data are presented as a dot plot (showing individual sample values), and the line indicates the average±S.E.M. (b) Peritoneal fluid
was collected from HCQ- and PBS-treated mice for cytokine/chemokine analysis. The data are presented as a dot plot (showing individual sample values) and the line represents
average± S.E.M. (c) Macrophages were stained with CD11b and F4/80 antibodies and then analyzed by flow cytometry. Representative images of the raw flow cytometry data
are shown. The data are presented as a dot plot (showing individual sample values) and the line represents average± S.E.M. (d) Macrophages were collected from the same
specimens analyzed in (b). Macrophages were stained as described in (c). Representative images of the raw flow cytometry data are shown. The data are presented as a dot plot
(showing individual sample values) and the line represents average±S.E.M
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horns derived from HCQ-treated mice, n=10). Interestingly,
as shown in Figure 1f, we observed an irregular epithelium
pattern in 5 out of 10 uterine horns derived from HCQ-treated
mice compared with those derived from PBS-treated mice. In
addition, we noted that the ectopic growths from HCQ-treated
mice did not histologically resemble endometriotic lesions
(i.e., did not contain the expected glandular components),
whereas those treated with PBS did (Figure 1f, black arrow-
heads indicate glandular compartments, while black arrows
indicate epithelial cells within the lesions) (P=0.03, per
Fisher’s exact test). Taken together, these results reveal that
HCQ reduces the number of endometriotic lesions and alters
the cellular organization within these tissues.
Altered levels of peritoneal macrophages and IP-10
cytokine from HCQ-treated mice. To investigate changes
in the inflammatory response to endometriosis, we quantified
32 cytokines/chemokines in the peritoneal fluid collected from
control (n= 4) and recipient (n=3) mice using a mouse
cytokine and chemokine magnetic bead panel assay. Of the
32 analyzed cytokines/chemokines, we identified that G-CSF,
eotaxin, and IP-10 (10 kDa interferon-γ-induced protein; also
known as CXCL10) were within the sensitivity and detection
limits of the assay; however, there were no significant
differences in these proteins between control and recipient
mice (Figure 2a). In contrast, we identified that IP-10 was
significantly increased (P= 0.0079) in peritoneal fluid
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Figure 3 Immunohistochemical analyses of murine endometria, ovaries, and lesions. (a) Representative immunohistochemical images of uterine horns and ovaries from
PBS- and HCQ-treated mice are shown. The cores were processed for H&E staining as well as epithelial and stromal markers (CK8 and vimentin, respectively), ovarian hormone
receptors (ER α and PR), and the autophagy marker LC3B. (b) Representative immunohistochemical images are shown from lesions collected from PBS- and HCQ-treated mice.
The sections were stained as described in (a). (c) Representative images of antibody immunohistochemical staining controls (both positive and negative staining) are shown. For
LC3B, mouse brain was used as a positive staining control tissue. For PR and ER α, mouse mammary glands were used as positive staining control tissues. For vimentin and
CK8, mouse uterine horns were used as positive staining control tissues. Negative staining controls were performed in the absence of primary antibody. The images of PR-
positive and -negative staining controls are shown at 20 × magnification; all other images are shown at 10 × magnification
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obtained from HCQ-treated mice (n=5) compared with PBS-
treated mice (n=5), whereas G-CSF and eotaxin remained
unchanged (Figure 2b).
As previous research identified a significant increase in
macrophage numbers in endometriosis-induced mice22 and
that HCQ can inhibit cytokine production in human macro-
phages,23 we therefore assessed macrophage numbers in
control, recipient (untreated), PBS-treated, and HCQ-treated
recipient mice. There was no significant change in the
macrophage numbers present in the peritoneal cavity of
control and endometriosis-induced mice at the time of
sample collection (2 weeks post-induction), using the cano-
nical macrophage markers CD11b and F4/80 (Figure 2c).
However, we did find a significant increase (P= 0.0079) in
macrophage numbers in HCQ-treated mice compared with
PBS-treated mice (Figure 2d). These data indicate that HCQ
alters the inflammatory response of endometriosis-
induced mice.
HCQ induces cellular disorganization in murine endome-
triotic lesions and eutopic endometrial. To determine
whether HCQ treatment alters the histopathology (tissue
organization) of the recipient’s uterine horns and other
tissues, we developed a murine tissue microarray (TMA)
comprised of 113 cores and performed H&E as well as
immunohistochemical staining. The TMA contained uterine
horns and ovaries from 10 PBS- and 10 HCQ-treated mice,
as well as a mammary gland, a kidney, a lymph node, and a
small intestine from a PBS-treated mouse for use as antibody
controls. Based on H&E staining, we observed that the
luminal epithelium of the uterine horn endometrium from
HCQ-treated mice had an irregular pattern (Figure 3a).
However, vimentin and cytokeratin 8 (CK8) appeared to be
appropriately localized to the stromal and epithelial compart-
ments, respectively, independently of HCQ treatment. As
expected, estrogen receptor α (ER α) was primarily localized
to the epithelial cell layer of the endometrial glands, whereas
progesterone receptor (PR) appeared to be evenly distributed
between the stromal and epithelial cell compartments;24
however, the PR staining was comparatively much weaker to
that for ER α. Again, no differences were noted in the tissues
from PBS- and HCQ-treated mice for ER α and PR staining
pattern or intensity. LC3B expression appeared more intense
in HCQ-treated mice relative to PBS-treated mice in both the
stromal and epithelial compartments (Figure 3a). We also
stained for the same immunohistochemical markers in
ovaries, but we did not observe any marked differences
in the intensity or localization pattern of any of these proteins
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Figure 4 Autophagy gene expression and protein levels are decreased in uterine horns and lesions from endometriosis-induced mice, independently of HCQ treatment.
(a) A subset of samples was analyzed to quantify transcript levels of autophagic markers by real-time PCR. The line indicates average± S.E.M. (b) Protein expression was
assessed by western blot analyses across the indicated groups using the indicated antibodies. Pan-actin was used as a loading control. The selected western blot presented in
the panel is representative of the data obtained across all of these specimens analyzed and includes: (1) PBS-treated mice: uterine horns (n= 5); (2) HCQ-treated mice: uterine
horns (n= 5); (3) PBS-treated mice: lesions (n= 5); and (4) HCQ-treated mice: lesions (n= 2). UH, uterine horns; FM, mass located near fat; LL, lesion located on the liver; SL,
lesion located near the surface of the peritoneal cavity; UHL, lesion located near the uterine horn; FBFL, blood-filled lesion located near the fat; FRL, red lesion located near the
fat; ML, lesion located near the mesentery. (c) Densitometric analyses of the presented western blots (as presented in (b)) are shown (presented as average± S.E.M.). For
GABARAPL1 and p62, analysis of the short exposure is shown. For FOXO1, analysis of the long exposure is shown
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in these tissues from HCQ-treated mice relative to those from
PBS-treated mice.
A certified pathologist confirmed epithelial and stromal
components in the lesions analyzed. Lesions (independent
blocks and not on the above-described TMA (see Materials
and Methods)) were also immunostained for CK8, vimentin,
ER α, and PR, and LC3B (Figure 3b). The epithelial cells of the
glands were positive for CK8, ER α, and PR expression, which
provides supporting data that the collected lesions originated
from endometrial tissue (Figure 3b). Interestingly, there was an
absence of glandular components in four out of the seven
stained lesions from HCQ-treated mice as demonstrated by
CK8, ER α, and PR immunohistochemical staining. These
results (with the H&E data presented in Figure 1f) suggest that
HCQ alters the organization of ectopic growths in the murine
model of endometriosis. Figure 3c displays representative
images of positive and negative staining controls for the
antibodies used.
Induction of endometriosis downregulates mRNA and
protein expression of autophagic markers in ectopic
compared with eutopic murine endometrium. To deter-
mine whether the expression of autophagic mediators in
uterine horns and lesions differs between PBS- and HCQ-
treated mice, we used real-time PCR to quantify the mRNA
transcript levels of 10 major molecules involved in the
autophagic pathway. In PBS-treated animals, we determined
that the mRNA levels of ATG5 (P= 0.0294), ATG4B
(P=0.0004), ATG2B (P= 0.0440), and beclin-1 (Po0.0001)
were significantly decreased in the analyzed endometriotic
lesions compared with uterine horns (uterine horns from
PBS-treated mice, n= 14; lesions from PBS-treated mice,
n= 28; uterine horns from HCQ-treated mice, n= 15; and
lesions from HCQ-treated mice, n= 7) (Figure 4a). Owing to
limited sample availability, LC3B and ATG2B were analyzed
using a smaller number of samples (i.e., for LC3B: uterine
horns from PBS-treated mice, n=9; lesions from PBS-
treated mice, n= 18; uterine horns from HCQ-treated mice,
n= 10; and lesions from HCQ-treated mice, n= 4; For
ATG2B: uterine horns from PBS-treated mice, n= 5; lesions
from PBS-treated mice, n=10; uterine horns from HCQ-
treated mice, n= 5; and lesions from HCQ-treated mice,
n= 2). No significant differences were noted between lesions
and uterine horns from HCQ-treated C57BL/6 mice (likely
due to smaller lesion numbers available in the HCQ group,
although similar trends were apparent). However, lesions
obtained from these HCQ-treated mice had a significant
increase in ATG5 (P=0.0499) and ATG3 (P= 0.0248)
compared with lesions from PBS-treated mice (Figure 4a).
We also used the Balb/c mouse strain for the induction
model to demonstrate that the changes observed in autop-
hagy gene expression are independent of the mouse genetic
strain used.20 In this model, we identified that the mRNA levels
of ATG7 (P= 0.0174), ATG4B (P= 0.0020), and beclin-1
(Po0.0001) were significantly reduced in endometriotic
lesions (n=8) compared with uterine horns (n=8) derived
from the same recipient mice (Supplementary Figure 3).
We next analyzed the protein levels of autophagic markers
in both lesions and uterine horns from PBS- and HCQ-treated
mice (Figure 4b) from the following groups: (1) PBS-treated
mice: uterine horns (n=15); (2) HCQ-treated mice: uterine
horns (n= 15); (3) PBS-treated mice: lesions (n=10); and
(4) HCQ-treated mice: lesions (n=7). LC3B-I, LC3B-II, LC3A-
I, and LC3A-II were decreased in lesions compared with
uterine horns from both PBS- and HCQ-treated mice.
Expression of GABARAPL1-I (GABA(A) receptor-associated
protein like 1) was detected in uterine horns collected from
both groups of treated mice and was decreased in the lesions;
however, the conjugated form, GABARAPL1-II, was not
observed in any of the murine specimens. We also observed
a decrease in p62 in endometriotic lesions relative to uterine
horns that was independent of HCQ treatment. FOXO1 and
AMPKα protein levels in the uterine horns were variable
among the samples analyzed, although they were both
reduced within the lesions (Figures 4b and c). To determine
whether HCQ treatment altered the expression of autophagic
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mediators in other organs, we harvested various tissue
specimens (kidneys, thymus, spleen, lung, pancreas, heart,
and liver) from each treatment group (five PBS-treated mice
and five HCQ-treated mice) and assessed LC3B levels
(Supplementary Figure 4). Among these tissues, only the
lung and heart showed differences in LC3B-II expression
following HCQ treatment. Overall, these results suggest
that the protein expression of autophagic mediators is
dysregulated in endometriotic lesions and is not affected by
treatment with HCQ in the majority of tissues analyzed,
including uterine horns.
RNA expression of autophagic markers is dysregulated
in eutopic endometria upon induction of endometriosis.
Evidence is accumulating that the eutopic endometria from
patients with endometriosis differs markedly from the eutopic
endometria from endometriosis-free subjects.25,26 To identify
changes in the expression of key autophagic markers in this
context, we used an RT2-PCR autophagy focused profiler
array to analyze RNA isolated from uterine horns from control
(non-induced) and recipient (untreated). In addition, we
compared the uterine horns from recipient mice with those
from PBS-treated recipient mice to verify that there was no
significant change that occurred upon intraperitoneal injection
with PBS. Three representative samples were selected from
each group based on RNA quality. A heat map comparing
gene expression in RNA isolated from uterine horns from
control mice to recipient mice is shown in Figure 5a; the
results indicate that there is a subset of autophagy genes that
is differentially expressed. A volcano plot is shown in
Figure 5b that displays the fold changes in autophagy genes
in eutopic endometria between recipient and control mice.
We identified 13 dysregulated genes (with statistical sig-
nificance) between these two groups of samples. Insulin-like
growth factor 1 (IGF1) was the only autophagic marker that
was significantly increased (P=0.044); the remaining 12
BNIP3
ATG9B
Increased ExpressionDecreased Expression
LC3A
IGF1
LC3B
PRKAA1
ATG4C
FAS
IRGM1
EIF2AK3
PTEN
GABARAPL1
SQSTM1
DRAM2
B2M
Figure 5 Decreased RNA expression of autophagic markers in eutopic endometria from mice with endometriosis relative to controls. (a) The selected RNA samples from
non-induced (control) and endometriosis-induced mice were analyzed using an RT2-PCR profiler array specific for 84 autophagy-related genes. A heat map shown depicting the
measured CT values across these specimens is presented. (b) A volcano plot is shown from the analyzed data presented in (a). The horizontal axis indicates significance
(P= 0.05) if targets are above the line; the dotted vertical bars denote at least a two-fold change in gene expression if targets are ⩾− 1 or 1 Log2 units. Red arrows indicate the
autophagic markers that were decreased42-fold with a P-value ofo0.05. (c) Validation using TaqMan real-time PCR of specimens used in (a)
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markers were all significantly decreased (BNIP3 (BCL2/
adenovirus E1B 19 kDa interacting protein), P=0.015;
ATG9B, P= 0.015; LC3A, P=0.007; LC3B, P=0.0012;
protein kinase AMP-activated, α1 catalytic subunit
(PRKAA1), P=0.023; ATG4C, P=0.031; FAS, P=0.003;
IRGM1 (immunity-related GTPase family M1), P=0.025;
GABARAPL1, P=0.045; PTEN (phosphatase and tensin
homolog), P=0.048; EIF2AK3 (eukaryotic translation initia-
tion factor 2-α kinase 3), P=0.043; and SQSTM1 (sequesto-
some 1), P= 0.054). As shown in Supplementary Figure 5,
we did not observe any significant changes upon PBS
treatment in the RT2-PCR array.
To validate these ‘top hits’ (i.e., increased by at least two-fold
with Po0.05) identified from the autophagic pathway
RT2-PCR profiler array, we performed real-time PCR using
TaqMan FAM-labeled probes/primers (Figure 5c and
Supplementary Table 1). Using this approach, we validated
10 of the 13 ‘top hits’ (Figure 5c): ATG4C (P=0.0167), ATG9B
(0.0113), EIF2AK3 (P=0.0068), FAS (P=0.0034), LC3A
(P=0.0306), LC3B (P=0.0040), GABARAPL1 (P=0.0360),
PTEN (P= 0.0295), SQSTM1 (P=0.0008), and PRKAA1
(P=0.0065) were significantly reduced. Although the majority
of the tested autophagic markers were not significantly
changed upon PBS treatment relative to recipient (untreated),
we did identify that the expression of EIF2AK3 (P= 0.0014)
was increased (Figure 5c). Taken together, these data suggest
that autophagy is dysregulated in the eutopic endometria of
endometriosis-induced mice.
Increased LC3 protein and lipid droplets in eutopic
endometria of endometriosis-induced mice compared
with eutopic endometria of controls. To determine
whether the RNA level changes of key autophagic markers
observed between the eutopic endometria of endometriosis-
induced mice (n= 10) and non-induced (control) mice (n= 10)
translated to protein level changes, we assessed their protein
levels via western blot analyses. As shown in Figure 6A
and Supplementary Table 2, beclin-1 (2.20-fold change,
P= 0.0330), LC3B-I (4.00-fold change, P=0.0185), LC3B-II
(6.76-fold change, P= 0.0364), LC3A-II (1.97-fold change,
P= 0.0135), and GABARAPL1 (1.95-fold change,
P= 0.0334) were significantly increased in uterine horns
from endometriosis-induced mice relative to those from
control mice. LC3A-I and LC3B-I have an expected molecular
weight of ~ 16 kDa, whereas LC3A-II and LC3B-II have an
expected molecular weight of ~ 14 kDa.27 When we assessed
GABARAPL1 expression, we did not detect the conjugated
form, suggesting that the primary form expressed in these
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tissues is the cytosolic form (GABARAPL1-I). To assess if the
increased levels of LC3B were specific to the uterine horns in
the endometriosis-induced mice, we analyzed LC3B protein
levels in homogenates prepared from kidneys, thymus,
spleen, lung, pancreas, heart, liver, and ovaries from both
recipient (n= 3) and control (n= 4) mice. Out of the nine
tissues analyzed, only the left kidney, spleen, and liver
appeared to show differences in LC3B-II levels
(Supplementary Figure 6).
To test whether the observed increases in LC3A and LC3B
correlated with an increase in autophagosome formation in
the eutopic endometria of endometriosis-induced mice, we
performed transmission electron microscope (TEM)
(Figure 6B). Although no autophagosomes were identified in
eutopic endometria from control mice (Figure 6Ba–d) and
eutopic endometria from endometriosis-induced mice (Figure
6Ce–g), we observed an increase in lipid droplet numbers in
the epithelial cells of eutopic endometria from endometriosis-
induced mice. In addition, we also observed more ‘unhealthy’
electron-dense epithelial cells in uterine horns from
endometriosis-induced mice (Figure 6Ce) compared with
control mice (Figure 6Ba). Taken together, these results
suggest that expression of autophagic mediators (i.e., LC3) is
dysregulated in the eutopic endometria of endometriosis-
induced mice, which is associated with an accumulation of
lipid droplets in the epithelial cells.
Immunohistochemical staining of LC3B in the epithelium
and stromal components of eutopic and ectopic endo-
metrium in patients with endometriosis. We next
addressed the cellular localization of LC3B within human
eutopic and ectopic endometrium by applying an immuno-
histochemical approach using a human endometriosis and
endometrium TMA.28 Representative immunohistochemical
images for endometrium (controls and patients) and lesions
(fallopian tubes, ovaries, peritoneal, gastrointestinal, and
skin) are shown (Figure 7a). We noted that LC3B was
localized primarily to the epithelium, although staining was
also noted in the stroma. To quantify the intensity of LC3B
expression at these specific cellular locations, we segmented
the sections using the H-score system into strong, moderate,
weak, or no expression (Figures 7b and c). The proportion of
strong expression was elevated in the epithelial cells of the
proliferative endometrium from cases (40.6%) and those from
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Figure 6 Increased protein expression of autophagy markers in the eutopic endometria from endometriosis-induced mice relative to controls. (A) Tissue homogenates from
uterine horns from non-induced and endometriosis-induced mice were analyzed for protein expression by western blotting (left panels). Pan-actin was used as the loading control.
A representation for 8 out of 10 total samples for both control and recipient groups is shown. Densitometric analyses of the presented western blots (right panels) are shown
(presented as average±S.E.M.). (B) Uterine horns from control and endometriosis-induced mice were analyzed by TEM and representative images of epithelial cells are shown.
(a–d) Eutopic endometria from control mice; (e–g) eutopic endometria from endometriosis-induced mice. The images on the right are magnifications of the indicated boxed region
in the respective left image
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ovarian and fallopian tube lesions (38.8% and 38.0%,
respectively). The endometriotic tissue with the highest
proportion of strong stromal expression was the gastrointest-
inal tract (GI) (17.4%), followed by proliferative endometrium
from controls (14.1%), proliferative endometrium from endo-
metriosis patients (13.6%), and secretory endometrium from
controls (12.0%) (Figures 7b and c). We noted a significant
difference in LC3B expression in the epithelium of secretory
endometrium compared with proliferative endometrium
(P= 0.0193) (Supplementary Figure 7, lower panel). We also
found significantly increased expression in the epithelium of
fallopian tube and ovarian endometriotic lesions compared
with epithelium from the secretory endometrium of controls
(P= 0.0220 and P= 0.0097, respectively). In the stroma of
peritoneal endometriotic lesions, LC3B was decreased
compared with the stroma of proliferative endometrium from
controls (P= 0.0101). In addition, relative to the stroma,
positive LC3B immunostaining was significantly more
Figure 6 Continued.
Autophagy in a mouse model of endometriosis
A Ruiz et al
12
Cell Death and Disease
elevated in the epithelial component of the lesions in the
fallopian tube, ovarian, and peritoneum but not in lesions
derived from the gastrointestinal tract and the skin
(Supplementary Figure 7, upper panel). Thus, collectively,
LC3B expression and localization was predominant in the
epithelium relative to the stromal components in all tissue
types assessed.
Discussion
To our knowledge, our work presented herein is the first to
investigate the effect of an autophagic flux inhibitor, HCQ, on
endometriotic lesion development and histopathology. Our
main findings are summarized in Figure 8. We found that HCQ
treatment affected the survival of human endometrial and
endometriotic cells in vitro, as well as decreased lesion
numbers using an in vivomouse model of endometriosis. The
drug also appeared to have an effect on lesion histopathology
(the absence of glandular components), but not on lesion size.
We also identified that HCQ increases the number of
macrophages and the IP-10 chemokine within the peritoneal
cavity of a mouse model for endometriosis. Furthermore, we
have identified that autophagic markers are differentially
expressed in uterine horns from endometriosis-induced mice
compared with those from control mice. Although we noted
that LC3B protein level was increased in eutopic endometria of
endometriosis-induced mice (compared with controls), we did
not identify increased autophagosomes by TEM in these
tissues. However, TEM showed that endometria from experi-
mental mice are less healthy and contained an increased
number of lipid droplets compared with endometria from
control mice. Finally, we noted that LC3B was expressed and
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Figure 7 LC3B is predominantly localized in the epithelium of ectopic and eutopic endometrium. (a) LC3B immunostaining was performed on a TMA containing biopsy cores:
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localized predominantly to the epithelia in all tissue types
(relative to the stroma) of human endometrium and endome-
triotic lesions from diverse locations using a TMA approach.
Chloroquine, and derivatives of this agent (including HCQ),
have been used to treat malaria, as well as inflam-
matory and autoimmune diseases.29 Endometriosis
shares some characteristics with autoimmune disorders,
such as increased inflammation, altered tissue-remodeling
components, dysregulated cell death pathways, increased
local and systemic cytokine levels.30 Inflammatory changes in
the peritoneal cavity may be associated with lesion
development.31 Other co-morbid autoimmune disorders (i.e.,
systemic lupus erythematosus, rheumatoid arthritis, multiple
sclerosis) can coincide with the presence of end-
ometriosis.32,33 These autoimmune disorders can be treated
with HCQ, which can antagonize communication among cells
in the immune system that are inappropriately activated.29,34
Therefore, HCQ could potentially be used as an effective
therapeutic agent for other autoimmune related disorders,
such as endometriosis. As described earlier, HCQ is
considered a lysosomotropic agent where it increases the
pH of acidic compartments and also inhibits the fusion of the
autophagosome with the lysosome.15–17 We identified a
marked reduction in cell survival with this agent in human
endometriotic and T-HESC cells. The involvement of lyso-
somes in endometriosis has yet to be investigated in detail; to
our knowledge, only one study describes changes in numbers
of lysosomes in the endometrium of women with
endometriosis.35 We also successfully knocked down ATG7
(in addition to other autophagic mediators) in T-HESC; we
noted amarked increase in p21 protein expression, which was
associated with attenuated cell viability with ATG7 siRNA
(Supplementary Figure 1e); changes were observed with
LC3B siRNA but only a subtle effect was noted with beclin-1
siRNA. However, with the exception of ATG5 and LC3B
knockdown, we failed to detect the expected reduction in LC3-
II to LC3-I ratio with PIK3C3 or beclin-1 siRNA (implicating a
noncanonical autophagic pathway), as well as with ATG7
siRNA (implicating autophagy independent role). In support, it
has been previously reported that ATG7 can lead to increased
p21 via a DNA damage pathway,36 which appears to be
independent of its canonical role in the autophagic pathway.
Therefore, it is possible that the reduction in cell viability could
have occurred via a similar noncanonical autophagy mechan-
ism or independently of autophagy. Further work is necessary
to clarify the nature of the contribution of these autophagic
mediators to endometriotic cell survival and lesion
development.
Although we identified increases in ATG5 and ATG3 in
lesions from HCQ-treated mice relative to PBS-treated mice,
the majority of the remaining autophagic markers that we
studied were unchanged; however, we recognize that this may
be because of a limited lesion number sample size obtained
from HCQ-treated mice. As we observed fewer glandular
structures and epithelial cells in lesions from endometriosis-
induced mice treated with HCQ, it is possible that this drug is
affecting the epithelial cells of endometriotic lesions more than
the stromal cells, thus leading to a decrease in lesion number
and quality. Our analyses of autophagic markers (by real-time
PCR or western blotting) did not distinguish between stromal
and epithelial cells; therefore, further tests would be required
to dissect the response between the two cell types that may be
leading to the observed decrease in lesion number.
HCQ treatment increased the levels of IP-10 and the
numbers of macrophages in the peritoneal cavity in our mouse
model of endometriosis. In humans, IP-10 has been reported
to attract monocytes and T lymphocytes, as well as decrease
angiogenesis.37,38 A decrease in IP-10 peritoneal levels has
been reported in advanced stages of endometriosis in
patients, and thus decreased levels of IP-10 may contribute
Figure 8 Schematic of overall results. Injected fragmented uterine horns implanted and developed in endometriotic lesions. LC3B and lipid droplets were elevated in recipient
uterine horns compared with uterine horns from recipients, as indicated by protein analyses and TEM, respectively. HCQ reduced lesion numbers relative to PBS treatment.
Moreover, IP-10 levels and macrophages increased in the peritoneal cavity of HCQ-treated mice compared with those treated with PBS
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to lesion development, permitting angiogenesis, and decreas-
ing recruitment of natural killer cells and their cytolytic
effects.39 Therefore, an increase in peritoneal IP-10 levels in
HCQ-treated mice may have created an unfavorable environ-
ment for lesion development. Whether IP-10 modulates the
autophagic pathway requires further investigation. It is
interesting that another chemokine CXCL12 has recently
been implicated in modulating autophagy in human secretory
phase endometrial stromal cells.40 Additional experiments will
be required to determine whether the HCQ effects leading to
the increased IP-10 levels corresponds with the observed
decrease in lesion number and the mechanisms whereby
IP-10 could be exerting its anti-endometriotic growth effects.
A previous study reported altered gene expression in
eutopic endometria from patients with endometriosis com-
pared with those of controls,41 suggesting that endometriosis
may be altering the endometria of patients. In our study, we
noted that the mRNA expression of autophagic markers was
generally decreased in eutopic endometria from endo-
metriosis-induced mice when compared with eutopic endo-
metria of control mice. Specifically, we found that transcript
levels of beclin-1, ATG5, ATG4B, and ATG2B were signifi-
cantly decreased in endometriotic lesions compared with
uterine horns (from endometriosis-induced mice treated with
PBS). Beclin-1 is required for vesicle nucleation during
autophagosome formation and forms a complex with UVRAG
to regulate PIK3C3.10 ATG5 and ATG4B are required to
generate the cytosolic form of LC3, LC3-I.42–44 In addition, we
found that LC3B protein levels were decreased in lesions
compared with uterine horns. Taken together, these changes
suggest that dysregulation of autophagic markers may alter
the autophagic response in endometriosis. Further research is
needed to determine whether autophagosome numbers are
altered within ectopic lesions. In contrast to the observations in
the lesions, we identified increased protein levels of beclin-1,
LC3B, LC3A, and GABARAPL1 in uterine horns from
endometriosis-induced mice compared with uterine horns
from controls, with a concurrent increase in lipid droplets. Lipid
droplets have been previously described in bovine endome-
trial epithelial cells,45 and recent findings have implicated LC3
in intracellular lipid droplet formation.46 It is possible that the
observed increases in LC3B protein are associated with the
accumulated lipid droplets, but further work is needed to
understand the clinical implications of this finding.
The observed changes in the expression of autophagic
markers in eutopic endometria from induced mice could be
explained by an activated local immune/inflammatory
response caused by transferring endometrial fragments into
the peritoneal cavity.3 Although we did not observe an
increase in inflammatory markers or macrophage levels
2 weeks post-induction, we propose that any inflammatory
response that occurred may have been diminished by the time
of sample collection. Taken together, these observations may
reveal why endometriosis is able to recur in women after
surgical removal of endometriotic lesions.47 Whether the
eutopic endometrium of women with endometriosis is altered
before lesion establishment or whether it becomes more
compromised after the initiation and establishment of the
disease remains unclear and requires further study.
In contrast to the reduced expression of LC3B protein in
lesions obtained from the mouse model of endometriosis
(relative to uterine horns isolated from the same diseased
mice), we identified an increase in LC3B levels in epithelial
cells of endometriotic lesions and in eutopic endometria of
endometriosis patients compared with endometrium from
controls using immunohistochemistry. We propose that this
difference may be due to the possibility that the murine
endometriosis lesions are equivalent to an early stage of
endometriosis in patients. As the human disease is not
diagnosed until a delay period of 7–10 years,48,49 the nature of
the isolated lesions from human may be more advanced. In
addition, the endometrium controls on the TMA are from
women with other gynecological problems, which is a
limitation of our study. Despite these limitations, the results
obtained with the human TMA are more close to the real-life
scenario of patient heterogeneity in clinical presentations and
history of disease (previous treatments, years with disease)
and still the changes in LC3B remained significant.
Whether the aforementioned observed expression changes
implicate autophagy dysregulation in a pro-survival or pro-
death manner is currently unknown with regard to endome-
triotic lesion establishment. Additional studies will be required
to determine howautophagy is regulated to allow development
of endometriosis. Our results also show potential for a novel
therapeutic approach for treating patients with this disease.
Patients with autoimmune diseases (i.e., lupus and arthritis)
appear to tolerate HCQ treatment well; side effects include
retinal damage with only rare reports of systemic reactions.50
Thus far, there seems to be no adverse effects of this drug on
fertility,51 which makes HCQ superior to the current use of
estroprogestinic treatments.
Materials and Methods
Ethics and TMA. All protocols in this study were approved by the Institutional
Review Board at the Ponce Research Institute (Ponce, Puerto Rico). Samples in the
TMA were obtained in a de-identified manner from archived samples at a private
pathology laboratory (Southern Pathology Laboratories in Ponce, Puerto Rico).
Details regarding the human TMA used in this study have been described
previously.28 Briefly, the TMA contains 164 cores, which is comprised of lesions
(from the ovaries (n= 29), fallopian tubes (n= 16), peritoneum (n= 34), skin
(n= 4), and gastrointestinal tract (n= 7)), eutopic endometrium from endometriosis
patients (n= 22), as well as secretory (n= 38) and proliferative (n= 14)
endometrium from endometriosis-free patients. The patients and controls recruited
into this biobank were not currently or have been for at least 3 months before
surgery on any hormonal medication.
Animal handling
C57BL/6 mouse model: Five-week-old C57BL/6 female mice were purchased
from Jackson Laboratories (Bar Harbor, ME, USA). All animals were maintained
under standard 12-h photoperiod; food and water were available ad libitum
throughout the study. All experimental procedures and animal care were approved
by the Animal Care and Use Committee (IACUC) of the University of South Florida
(R IS00000101), in accordance with the principles described in the Guide for the
Care and Use of Laboratory Animals of the National Institutes of Health. All surgical
procedures were performed under aseptic conditions using anesthesia. The mouse
model of endometriosis was performed as described previously.19,20 Donor animals
received a peritoneal injection of 3 μg per mouse of β-estradiol-17-valerate (Sigma,
St. Louis, MO, USA); the dose used was based on previously reported data.20 One
week after estrogen injection, donor animals were killed and each uterine horn
was collected and minced using a Kirkland Tissue Mincer (Kirkland Products,
Portland, OR, USA) with sterile normal saline. The minced material was centrifuged
at 1500 r.p.m. for 1 min. Endometriosis was induced by injecting the uterine horn
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fragments intraperitoneally into the recipient animal. Mice were then randomly
divided into two groups: HCQ treatment animals were intraperitoneally injected with
100 μl of 60 mg/kg of HCQ (No. AC26301; Fisher Scientific, Pittsburgh, PA, USA),
whereas control treatment animals received an intraperitoneal injection of 100 μl
sterile PBS. The dose for HCQ used was based on previously published data and
was comparable to doses used in treating patients with autoimmune diseases.21 A
second HCQ treatment was administered 1 week after endometriosis induction,
using the same dose. Two weeks after induction, mice were killed and tissues
(including lesions) were snap frozen into liquid nitrogen. Lesions were measured
using a caliper. Volume of the lesions was calculated according to the formula:
4/3πr2R.52
Balb/c mouse model: Eight-week-old Balb/c female mice were obtained from
the Charles River Laboratories (Calco, Como, Italy) and handled as described
previously19,20 and in accordance with the European Union guidelines, as well as
with the approval of the Institutional Animal Care and Use Committee of San
Raffaele Scientific Institute (Protocol No. 484) (Milan, Italy). Briefly, donor mice were
injected with 17β-estradiol (AMSA, Rome, Italy; 3 μg per mouse) and killed 1 week
later. The uterus was removed and fragmented, after scraping to remove the
myometrium, using scissors. The endometrial tissues were weighed and
resuspended in saline with ampicillin (1 mg/ml). Two recipient mice received an
intraperitoneal injection, using a syringe containing half of the resuspension (day 0).
Mice were killed by administering a lethal dose of anesthetic on day 12. The
abdomen was opened and lesions were isolated and collected by an operator
blinded to the experiment.
Cell culture of life-extended human endometriotic and T-HESC
cells, HCQ treatment, siRNA transfection, and survival assay.
Primary human endometriotic cells culture conditions and life extension have been
described previously.18 These cells were derived from peritoneal (‘C') and ovarian
(‘D’) lesions obtained from two independent patients. These were assessed
separately as described below. Briefly, cells were maintained in MCDB 131:Medium
199 (1 : 1 ratio) supplemented with 8% fetal bovine serum (FBS), penicillin/
streptomycin, and insulin/transferrin/selenium (ITS). Cells were life extended using
simian virus 40 large T antigen. Retroviral particles generated in HEK293T were
used to infect the primary cells. Media containing puromycin (2.5 μg/ml) was used to
select primary cells resistant colonies. In addition, we obtained the T-HESC cell line,
which are human endometrial stromal cells derived from a uterine myoma (ATCC,
Manassas, VA, USA). This cell line was maintained in phenol red-free DMEM/F12
(1 : 1) containing 8% charcoal-dextran-treated FBS, 500 ng/ml puromycin, 1% ITS+
Premix (BD Bioscience, San Jose, CA, USA), and 15 mM HEPES. The cell lines
used in the present study were tested to be mycoplasma negative and short tandem
repeat profiled (Genetica DNA Laboratories, Cincinnati, OH, USA). Endometriotic
cells were seeded at 50 000 cells per well in a 24-well plate, whereas T-HESC cells
were seeded at 250 000 cells per well in a 6-well plate. A 50 mM HCQ (no.
AC26301; Fisher Scientific, Pittsburgh, PA, USA) stock was prepared in PBS (and
0.22 μm filter sterilized); it was used at a final concentration of 25 μM in complete
media.18,53 Cells were treated for 18 h with HCQ before protein harvest and western
blotting analyses. For survival studies, cells were seeded at a density of 5 000 cells
per well in a 96-well opaque plate and treated with 25 μM HCQ during 5 days. Cell
viability was then assessed using CellTiter-glo reagent (Promega, Madison, WI,
USA).18
For siRNA transfection studies, T-HESC cells were seeded at 350 000 cells per
well in a 6-well plate. After overnight adherence, cells were then transfected with
either non-targeting control siRNA, ATG5, beclin-1, ATG7, PIK3C3, or LC3B siRNA
according to previously described methods.18,54 The day after the second round of
siRNA transfection, cells were reseeded at 5 000 cells per well in opaque 96-well
plates. Three days after reseeding, cell viability was assessed using CellTiter-glo
reagent as described above.
Immunohistochemistry of LC3B. Samples in the TMA were collected in a
de-identified manner from archived samples in a Pathology Lab as described in
Human Subjects above. Briefly, slides were deparaffinized and stained using the
automated system Ventana Discovery XT (Ventana Medical Systems, Tucson, AZ,
USA) with EZ Prep solution. The heat antigen retrieval method was performed at a
pH of 8.0. The primary antibody, LC3 (AP1802a), that detects LC3B was obtained
from Abgent (San Diego, CA, USA) and diluted at a ratio of 1 : 25 in Dako antibody
diluent (Dako, Carpenteria, CA, USA), followed by a 32 min incubation at room
temperature. Human breast cancer tissue was used as a positive control and the
primary antibody was omitted for the negative control. Ventana OmniMap anti-rabbit
secondary antibody and the Ventana Medical Systems (Tucson, AZ, USA) as the
detection system were used. Hematoxylin was used as the counterstain.
The LC3-stained TMAwas then scanned using the Aperio ScanScope XT (Aperio,
Vista, CA, USA) with a × 200 magnification and a 0.8 numerical aperture objective
lens via the Basler tri-linear array detection. Each core was then segmented using the
TMA block software associated with the Spectrum program (version 10.2.5.2352),
followed by manual segmentation into epithelial and stromal regions under the
supervision of a pathologist. Image analysis was performed using an Aperio Positive
Pixel Count v.9.0 algorithm with the following thresholds: Hue Value= 0.1; Hue
Width= 0.5; Color Saturation Threshold= 0.04; IWP(High)= 220; IWP(Low)= IP
(High)= 175; IP(low)= ISP(High)= 100; ISP(Low)= 0 to segment positive staining
of various intensities. The data were then compiled for each core in the separate
epithelium and stromal regions, which was represented by percent positivity, and then
directly correlated with protein expression.
RNA isolation, real-time PCR, and RT2-PCR. Total RNA was isolated
using the RNeasy Kit following the manufacturer’s instructions (Qiagen, Valencia,
CA, USA). RNA concentration and purity was determined using a 1000 NanoDrop
(Thermo Scientific, Pittsburgh, PA, USA). Lesion mass varied by samples, and this
was reflected in the RNA amounts obtained (range of mass: 0.9–25 mg).
Three RNA samples from uterine horns, having a 260/280 ratio 41.8 and a
260/230 ratio 41.7, were selected from recipient, donor, HCQ-treated, and PBS-
treated animals (12 samples in total) for RT2-PCR analyses. Synthesis of cDNA was
performed using 0.5 μg of total RNA, after DNA elimination step using the RT2 First
Strand Kit as per the manufacturer's instruction (Qiagen). After DNA elimination, the
reaction mix was incubated at 42 °C for 15 min, followed by 95 °C for 5 min using a
DNA Engine Peltier Thermal cycler (Bio-Rad, Hercules, CA, USA). A total of 102 μl of
the cDNA reaction mix was added to the master mix containing 1248 μl of
RNAse-free water and 1350 μl of 2x RT2 SYBR green master mix. Twenty-five
microliters of the master mix were carefully added to each well of the RT2 profiler PCR
autophagy array. Quantification was performed using the Applied Biosystems cycler
(Life Technologies, Grand Island, NY, USA). The PCR cycling program included
activation for 10 min at 95 °C, followed by 40 cycles for 15 s at 95 °C with 1 min
at 60 °C. The PCR cycling program finalized with a melt-curve analysis and data was
analyzed using the Qiagen web-based software (http: //www.SABiosciences.com/
pcrarraydataanalysis.php).
For real-time PCR studies, the One-step Master Mix (Applied Biosystems, Foster
City, CA, USA) was used with the following probes and primers as described
previously:18 LC3B, Mm00782868_sH; ATG4B, Mm01701111_m1; ATG9A,
Mm01264420_m1; ATG5, Mm00504340_m1; ATG7, Mm00512209_m1; ATG3,
Mm00471287_m1; PIK3C3, Mm00619489_m1; ULK1 (unc-51-like autophagy-
activating kinase 1), Mm00437238_m1; ATG9B, Mm01157883_g1; Beclin-1,
Mm01265461_m1; ATG2B, Mm00512973_m1; ATG4C, Mm01259886_m1; BNIP3,
Mm01275600_g1; EIF2AK3, Mm00438700_m1; FAS, Mm01204974_m1; LC3A,
Mm00458725_g1; GABARAPL1, Mm00457880_m1; IGF1, Mm00439560_m1;
IRGM1, Mm00492596_m1; SQSTM1 (p62), Mm00448091_m1; PRKAA1,
Mm01296700_m1; PTEN, Mm00477208_m1. CT values were normalized to β-actin
(Mm00607939_s1) and RNA fold changes were determined using the 2−ΔΔCT
equation.
Protein isolation, SDS-PAGE, and western blot analyses. Tissues
used for protein analyses included uterine horns, ectopic lesions, ovaries, thymus,
kidneys, heart, pancreas, spleen, and liver. Samples were flash frozen in liquid
nitrogen and stored at − 80 °C until use. Tissues were homogenized in ice-cold lysis
buffer containing 1% Triton X-100, 50 mM HEPES, 150 mM NaCl, 1 mM MgCl2,
1 mM EGTA, 10% glycerol, and protease inhibitor cocktail (Roche, Indianapolis, IN,
USA) using a PowerGen 125 homogenizer (Fisher Scientific, Pittsburgh, PA, USA).
Samples were centrifuged at 14 000 r.p.m. for 10 min at 4 °C. The supernatants
were collected and total protein concentration was determined using the BCA assay
(Thermo Scientific, Rockford, IL, USA), and a BioTek synergy 2 microplate reader
(BioTek, Winooski, VT, USA). Samples were normalized and then run onto 10 or
12% SDS-polyacrylamide gels prepared in a Criterion Cassette system (Bio-Rad,
Hercules, CA, USA) as described previously.54 The following antibodies and
dilutions were used: LC3B rabbit polyclonal (no. 2775, 1 : 1 000), LC3A rabbit
monoclonal (no. 4599 (D50G8), 1 : 1 000), Beclin-1 rabbit polyclonal (no. 3738,
1 : 1,000), GABARAPL1 rabbit monoclonal (no. 13733 (E1J4E), 1 : 1000), AMPKα
rabbit monoclonal (no. 2603 (23A3), 1 : 500), FOXO1 rabbit monoclonal (no. 2880
(C29H4), 1 : 1000), and pan-actin rabbit polyclonal (no. 4968, 1 : 500) were all
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obtained from Cell Signaling Technology (Danvers, MA, USA). The p62 mouse
monoclonal antibody (no. 610832, 1 : 1 000) was obtained from BD Biosciences
(San Jose, CA, USA).
Hematoxylin/eosin staining, TMA construction, and immunohis-
tochemistry. Collected samples were immediately preserved in 10% neutral-
buffered formalin at the animal facility. Samples were embedded in paraffin,
sectioned, and transferred to slides for hematoxylin/eosin and immunohistochemical
staining. A pathologist reviewed each case and delimited the region of interest,
containing epithelial and stromal cells, for each specimen. A mouse TMA was
prepared at the Tissue Core Facility at the Moffitt Cancer Center. The mouse TMA
contained a total of 113 core samples, which included 10 uterine horns and 10
ovaries from both PBS- and HCQ-treated mice. As control specimens for the
antibodies used, the TMA included mouse mammary tissue, liver, small intestine,
and lymph nodes from a PBS-treated mouse. Lesions were analyzed from
independent blocks. Slides were stained using a Leica Bond RX automated system
(Leica Biosytems, Buffalo Grove, IL, USA) following the manufacturer's instructions
with proprietary reagents. Slides were deparaffinized on an automated system with
Dewax Solution (Leica Biosystems). The antigen retrieval method used for PR was
enzymatic with Enzyme Solution 1 at 15 min (Leica), for vimentin and ER was
heat induced with Epitope Retrieval Solution 1 at 20 min (Leica), for CK8 was heat
induced with Epitope Retrieval Solution 2 at 10 min (Leica), and for LC3B was
heat induced with Epitope Retrieval Solution 1 at 10 min (Leica Biosystems).
All antibodies were diluted in Dako antibody diluent (Dako): PR (no. ab131486,
1 : 500; Abcam, Cambridge, MA, USA), vimentin (no. 5741 (D21H3), 1 : 100; Cell
Signaling), ER α (no. ab32063 (E115), 1 : 200; Abcam), CK8 (no. ab53280 (EP1628Y),
1 : 200; Abcam), and LC3B (no. ab51520, 1 : 1500; Abcam) and incubated for 30 min.
The Leica Bond Polymer Refine Detection System Leica Biosystems was used with a
polymer incubation for 8 min. Hematoxylin was used as a counterstain, and slides were
dehydrated and covered with a coverslip, following standard histological protocol.
Analysis of murine peritoneal inflammatory molecules. After
animals were killed, 1 ml of sterile PBS was injected into the peritoneal cavity,
the abdominal area was gently massaged, and the fluid collected. The collected
fluid was centrifuged at 1390 r.p.m. for 5 min at 4 °C and the resulting supernatant
was then stored at − 80 °C. Levels of chemokines and cytokines were analyzed
using a MCYTOMAG-70K-PX32 (Millipore, Billerica, MA, USA) following the
manufacturer’s instructions. Briefly, 200 μl of wash buffer was added to each well
and incubated for 10 min at room temperature in a plate shaker. After incubation,
the wash buffer was decanted and the plate was inverted and tapped on absorbent
towel several times. Then, 25 μl of assay buffer was added to each well, followed by
25 μl of concentration standards, assay controls, or samples. The premixed bottle
was vortexed and 25 μl of the beads were added to each well. The plate was
incubated overnight at 4 °C, and then protected from light. Then, the plate was
incubated for 1 min on the hand-held magnet and the well content was gently
decanted and tapped on absorbent pads. Each well was washed two times using
200 μl of wash buffer, followed by the incubation on the hand-held magnet. Antibody
detection solution was allowed to warm to room temperature, and then 25 μl was
added to each well and incubated for 1 h at room temperature on a plate shaker,
protected from light. Next, 25 μl of streptavidin-phycoerythrin was added to each
well containing the detection antibodies and incubated for 30 min at room
temperature protected from light on a plate shaker. After the incubation, the plate
was washed two times as previously described and 150 μl of sheath fluid was
added to each well. The plate was analyzed using MAGPIX instrument and
xPONENT software solutions, version 4.2 Luminex Corporation (Austin, TX, USA).
Flow cytometry. The pellet obtained after centrifugation of the peritoneal fluid
wash (see above) was used for macrophage staining. When necessary, red blood
cell lysis was performed according to the manufacturer’s protocol (eBioscience, San
Diego, CA, USA). The cell pellets were resuspended in 1 ml cold PBS and
transferred to flow cytometry tubes. Samples were centrifuged for 1 min at 1390 r.p.
m. The supernatant was decanted and cells were resuspended in 100 μl of PBS.
Cells were blocked using 0.5 μg of Mouse BD Fc, Block (no. 553141; BD
Pharmingen, San Jose, CA, USA) for 5 min on ice. The cells were incubated in
0.4 μg of APC rat anti-mouse CD11b clone M1/70 (no. 553312; BD Pharmingen)
and anti- mPE-F4/80/EMR1 (no. FAB5580C; R&D Systems, Minneapolis, MN, USA)
at room temperature for 30 min, protected from light. After incubation, 700 μl of PBS
was added to each tube and centrifuged for 1 min at 4 °C. The supernatant was
decanted, and the cells were resuspended in 300 μl in PBS and analyzed by flow
cytometry.
Transmission electron microscopy. Following induction of anesthesia,
the abdominal cavity of the mice was opened to expose the uterine horns. Both
uterine horns were removed and cut in cross-sections of 2–3 mm long pieces, which
were then rinsed in 0.1 M phosphate buffer to remove excess blood, and placed in
2.5% glutaraldehyde in 0.1 M sodium phosphate buffer, pH 7.2, at 4 °C. The tissue
was fixed in glutaraldehyde at 4 °C for 24 h. Following fixation, the tissue was rinsed
in buffer, sliced into 1-mm-thick rings and postfixed in 1% osmium tetroxide at 4 °C
for 2 h. Following buffer and distilled water rinses, the tissue was dehydrated
through a graded series of acetone dilutions, cleared with propylene oxide, infiltrated
overnight, embedded in LX 112 epoxy resin mix (Ladd Research, Williston, VT,
USA), and polymerized at 70 °C. Entire cross-sections of the uterine horns were
obtained at 0.25 –0.35 μm thickness and 70–80 nm thickness, and stained with 1%
toluidine blue stain (for light microscopy) or 8% uranyl acetate and Reynold’s lead
citrate (for electron microscopy), respectively. The endometrium of both control and
experimental animals was observed and photographed using an FEI Morgagni TEM
(FEI Company, Hillsboro, OR, USA) with an AMT ActiveVu camera (AMT, Woburn,
MA, USA).
Statistical analyses. All analyses were performed using GraphPad Prism
software (version 6.04; GraphPad, La Jolla, CA, USA). To calculate the significance
of the observed disorganization of epithelial cells in eutopic endometria from
endometriosis-induced mice treated with HCQ (compared with those treated with
PBS, as a control), we used the Fisher’s exact test. All other statistical analyses
were calculated using the nonparametric Student's t-test and error bars displayed
represent standard errors of the mean (S.E.M.). Statistical significance was set at
P⩽ 0.05 (*P⩽ 0.05, **P⩽ 0.01, ***P⩽ 0.001, and ****P⩽ 0.0001).
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